Since 1996, the Government of the Hong Kong Special Administrative Region (HKSAR) has introduced the Pay for Safety Scheme (PFSS) to the public works construction contracts to uplift their safety performance. However, the adoption of PFSS has also encountered some difficulties that merit considerable attention. This paper purports to provide a concise review of the prevailing application of PFSS in Hong Kong in general, and to explore the potential difficulties associated with PFSS in particular. By means of an empirical questionnaire survey geared towards industrial practitioners with extensive direct hands-on PFSS experience, their opinions were solicited, analyzed and compared between the client group and contractor group of respondents. The three most significant difficulties in implementing PFSS were found to be: (1) "Plenty of paperwork required for certifying payment to contractor"; (2) "Complicated contract documents and lengthy assessment process"; and (3) "Over-tight project schedule requiring rush jobs". The output of this research study is particularly essential in assisting the contracting parties to mitigate the avoidable hindrances when embarking on PFSS. It has also generated valuable insights into developing effective recommendations for alleviating the barriers to PFSS success for future construction projects.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.aap.2011.04.015 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Impact of Needle-Free Connector and Prefilled Flushing Syringe Shortage on CLABSI Rates in Pediatric Intensive Care.
Infect Dis Clin Microbiol
December 2024
Department of Pediatric Intensive Care Unit, Dr. Behçet Uz Children's Diseases and Surgery Training and Research Hospital, İzmir, Türkiye.
Objective: We aimed to discuss our experience of a higher incidence of catheter-associated bloodstream infections (CLABSIs) during the needle-free connector (NFC) and single-use prefilled flushing syringe (PFS) shortage.
Materials And Methods: Retrospective analyses were carried out to investigate the CLABSI rates at a tertiary training hospital from January 1, 2023, to December 31, 2023, and the study period included a three-month shortage of NFCs and PFSs in April and June 2023.
Results: The CLABSI rate for the three months was 5.
Glass Silicone Oil Free Pre-filled Syringe as Primary Container in Autoinjector.
Pharm Res
December 2024
Pharmaceutical Sciences & Clinical Supply, Merck & Co., Inc., Rahway, NJ, 07065, USA.
Objective: Pre-filled syringes (PFSs) have become popular as a convenient and cost-effective container closure system for delivering biotherapeutics. However, standard siliconized PFSs may compromise the stability of therapeutic proteins due to their exposure to the silicone oil-water interface. To address this concern, silicone oil-free (SOF) glass syringes coupled with silicone-oil free plunger stoppers have been developed.
View Article and Find Full Text PDFLow, but Not High, Pulsating Fluid Shear Stress Affects Matrix Extracellular Phosphoglycoprotein Expression, Mainly via Integrin β Subunits in Pre-Osteoblasts.
Curr Issues Mol Biol
November 2024
Department of Oral Cell Biology, Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam Movement Sciences, 1081 LA Amsterdam, The Netherlands.
Matrix extracellular phosphoglycoprotein (Mepe), present in bone and dentin, plays important multifunctional roles in cell signaling, bone mineralization, and phosphate homeostasis. Mepe expression in bone cells changes in response to pulsating fluid shear stress (PFSS), which is transmitted into cells through integrin-based adhesion sites, i.e.
View Article and Find Full Text PDFComplex MEFV and MVK Variations in a Syrian Child: Implications for Clinical Phenotypes and Treatment Response-A Case Report.
J Investig Med High Impact Case Rep
October 2024
Rheumatology Pediatric Department, Children's Damascus University Hospital, Damascus, Syria.
Article Synopsis
- A 10-year-old Syrian boy presents with mutations in both Mediterranean fever and mevalonate kinase genes, leading to symptoms of two rare conditions, Familial Mediterranean Fever (FMF) and Hyperimmunoglobulinemia D syndrome (HIDS).
- His symptoms include intermittent fever, recurrent respiratory infections, anemia, and growth failure, with an initial misdiagnosis of Still's disease and subsequent ineffective treatment.
- Genetic analysis shows significant mutations and the child's condition improves with corticosteroids and infliximab, though growth issues remain, raising questions about the interplay of the two genetic mutations in his clinical presentation.
PD-L1 as a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant NSCLC.
Anticancer Res
October 2024
Department of Internal Medicine, College of Medicine, Yeungnam University, Daegu, Republic of Korea;
Article Synopsis
- The study investigates the effects of durvalumab consolidation therapy on patients with non-small cell lung cancer (NSCLC) who have either mutant (EGFR M+) or wild-type (EGFR M-) epidermal growth factor receptors, specifically looking at programmed death-ligand 1 (PD-L1) expression levels.
- Of the 249 unresectable stage III NSCLC patients treated, only 12.4% had EGFR M+, with the median progression-free survival (PFS) being significantly longer in patients with high PD-L1 expression (≥50%) compared to those with EGFR M+ and low PD-L1 expression.
- The findings suggest that durvalumab can be beneficial for EGFR M+
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!